Early aspirin after aneurysm bleeding
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether giving aspirin early after a ruptured brain aneurysm is treated can help prevent complications like vasospasm (a narrowing of brain blood vessels) and improve recovery. It is for people who have already had the aneurysm secured within 48 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had a type of stroke called subarachnoid hemorrhage, which is bleeding in the space around the brain, confirmed by a CT scan.
- The bleeding was caused by a ruptured brain aneurysm that was successfully treated (either by surgical clipping or endovascular coiling) within 48 hours of the bleeding episode.
- Before the bleeding, you were able to live independently without significant disability.
- You do not have certain medical conditions that would make aspirin unsafe, such as active bleeding, severe liver or kidney disease, or a history of serious stomach bleeding.
- You are not currently taking antiplatelet medications like aspirin, clopidogrel, or ticagrelor for other health reasons.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether starting blood pressure lowering treatment earlier after aneurysm repair improves recovery. If you've recently had a bleeding brain aneurysm treated, this may help reduce complications.
This study follows people with a brain bleed from a ruptured aneurysm in real-world hospital settings. It aims to better understand delayed brain damage after the bleed, which could help improve care.
This trial tests if taking aspirin before and after a procedure to fix an unruptured brain aneurysm (coiling) helps prevent complications. Aspirin is a common blood thinner that might reduce the risk of blood clots or other problems after the procedure.
This trial tests if a medicine called cilostazol can reduce the risk of a delayed shortage of blood in the brain after having a bleeding aneurysm treated. It aims to improve recovery by preventing a common complication called delayed cerebral ischemia.
This trial tests whether the drug ticagrelor, which helps prevent blood clots, can reduce the risk of a stroke occurring days after a mild form of bleeding in the brain. It is given as an add-on to the standard treatment for the bleeding aneurysm.
This trial studies whether starting aspirin early is safe and helpful for people who, after clot-busting treatment for an ischemic stroke, develop a specific type of small brain bleeding called hemorrhagic infarction. You might benefit if your scan later shows this pattern of bleeding and you are not able to take blood-thinners or aspirin is safe for you.
Hear when a new Aneurysmal Subarachnoid Hemorrhage (aSAH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.